Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
Hepatocellular carcinoma (HCC) is estimated to have an annual worldwide incidence of 0.25 to 1.2 million new cases per year. Both the prevalence and incidence of HCC vary markedly as a function of geography and the local prevalence of chronic viral hepatitis. Both chronic hepatitis B and chronic hepatitis C are recognized as risk factors for HCC. The prevalence of cirrhosis in individuals with HCC and chronic hepatitis B or C is reported to be 80.9% and 75.8%, respectively. HCC occurs at a lower rate in chronic viral hepatitis in the absence of cirrhosis. Moreover, hepatitis C virus (HCV) rather than hepatitis B virus (HBV) is associated with the majority of non-cirrhotic cases of HCC. It is probable that the ongoing process of hepatocyte necrosis and liver cell renewal coupled with inflammation, which is characteristic of chronic viral hepatitis, causes not only nodular regeneration and cirrhosis but also progressive genomic errors in hepatocytes as well as unregulated growth and repair mechanisms leading to hepatocyte dysplasia and, in some cases, hepatic carcinoma. Current concepts concerning virus-induced HCC are reported and discussed in the following review.
Idilman
R
R
Transplant Center, Loyola University, Maywood, IL, USA.
De Maria
N
N
Colantoni
A
A
Van Thiel
D H
DH
D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000821:virology*; D016158:Genes, p53 / Q000235:genetics; D016174:Hepacivirus / Q000472:pathogenicity*; D006509:Hepatitis B / Q000150:complications; D006515:Hepatitis B virus / Q000235:genetics / Q000472:pathogenicity*; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000150:complications / Q000821:virology; D008113:Liver Neoplasms / Q000453:epidemiology / Q000821:virology*; D009857:Oncogenes / Q000502:physiology; D015995:Prevalence; D012307:Risk Factors; D015533:Transcriptional Activation / Q000235:genetics; D016662:Virus Integration / Q000235:genetics